ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto +12 more
wiley +1 more source
Abstracts from the 2026 joint meeting between MedStar Georgetown University Hospital's Functional Diabetic Limb Salvage: A Team Approach in collaboration with the Wound Healing Foundation, 8-11<sup>th</sup> April 2026, Washington, DC, USA. [PDF]
Parnell LKS, Steinberg J.
europepmc +1 more source
Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease. [PDF]
Wang Y +5 more
europepmc +1 more source
[Comments by Cicero MD to Santillán MD].
openaire +1 more source
Moxibustion combinations for diabetic peripheral neuropathy: a network meta-analysis of 40 randomised trials. [PDF]
Du D +5 more
europepmc +1 more source
Minimally invasive vs standard open carpal tunnel release: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials. [PDF]
Almarri AK +14 more
europepmc +1 more source
Same-day discharge does not increase complications or readmissions in carefully selected patients undergoing aseptic lower extremity nonunion surgery. [PDF]
Lauck BJ +18 more
europepmc +1 more source

